Analyst: Negotiation drug renewal rules exceed expectations, benefiting innovative drugs.

Zhitong
2023.07.04 05:59

The National Healthcare Security Administration is soliciting public opinions on the "Renewal Rules for Negotiated Drugs" and the "Bidding Rules for Non-Exclusive Drugs" today. According to an industry analyst, the new rules mainly have three changes: 1. Inclusion in the regular catalog. 2. The price reduction in this round of negotiations will take into account the previous reduction, which will be more moderate than before. 3. The renewal threshold has been raised. Exceeding market expectations, overall it is favorable for innovative drugs.

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.